{
  "symbol": "TIL",
  "company_name": "Instil Bio Inc",
  "ir_website": "https://ir.instilbio.com/",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "News Releases",
          "url": "https://ir.instilbio.com/news-events/news-releases",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# News Releases\n\nYear None2024202320222021\n\n2024\n\nNovember 13, 2024 \n\n[Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-third-quarter-2024-financial-results-and)\n\nSeptember 16, 2024 \n\n[Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer](/news-releases/news-release-details/instil-bio-and-immuneonco-announce-global-registrational)\n\nAugust 13, 2024 \n\n[Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-second-quarter-2024-financial-results-and)\n\nAugust 1, 2024 \n\n[Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody](/news-releases/news-release-details/instil-bio-and-immuneonco-announce-license-and-collaboration)\n\nMay 10, 2024 \n\n[Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-first-quarter-2024-financial-results-and)\n\nMarch 21, 2024 \n\n[Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-fourth-quarter-and-full-year-2023-financial)\n\nJanuary 16, 2024 \n\n[Instil Bio Announces Strategic Update](/news-releases/news-release-details/instil-bio-announces-strategic-update)\n\n[](# \"Back to top\")\n\n√ó\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://ir.instilbio.com/financial-information/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# SEC Filings\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -202420232022202120202019\n\n- Any -\n\nItems per page 102550\n\n10\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | Filing Group | View  \n---|---|---|---|---  \nNovember 21, 2024 | [EFFECT](/sec-filings/sec-filing/effect/9999999995-24-003547) | EFFECT |  Other |  [9999999995-24-003547.pdf](/static-files/60224ae6-8635-4703-9737-c19c4e4a7261) [9999999995-24-003547.rtf](/static-files/49ad1331-73d9-4aac-9824-d71bf0190a3a) [9999999995-24-003547.xls](/static-files/49631a9a-a982-4006-aeb3-bdc3b91ced76) [View HTML](/node/8041/html)  \nNovember 14, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001104659-24-119326) | An amendment to the SC 13G filing |  Other |  [0001104659-24-119326.pdf](/static-files/e19f0ba2-58b7-4d6e-9f7c-a7a5d936fe45) [0001104659-24-119326.rtf](/static-files/82411377-1c39-4262-b89e-e56ddca2f859) [0001104659-24-119326.xls](/static-files/4e2cc36c-d30f-4307-8744-fe8e0bd50dec) [View HTML](/node/8031/html)  \nNovember 14, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001213900-24-098624) | An amendment to the SC 13G filing |  Other |  [0001213900-24-098624.pdf](/static-files/bff4af8a-db83-41c0-8130-bf8d41360780) [0001213900-24-098624.rtf](/static-files/f0c66ea4-db6a-40b7-a96c-6ec8592371a8) [0001213900-24-098624.xls](/static-files/8a1dfc43-8956-4ccd-a76e-1517e88a5764) [View HTML](/node/8036/html)  \nNovember 13, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001789769-24-000100) | Report of unscheduled material events or corporate event |  Current Reports |  [0001789769-24-000100.pdf](/static-files/ebcad32e-b3ae-4cfc-b665-bc3b9e348d07) [0001789769-24-000100.rtf](/static-files/2e320edf-2d52-4783-9111-d11d3af987e0) [0001789769-24-000100.xls](/static-files/4a3bcfa8-da69-427d-b957-8184530f8cdf) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001789769-24-000100) [View HTML](/node/8016/html)  \nNovember 13, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001789769-24-000103) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings |  [0001789769-24-000103.pdf](/static-files/046a884d-e90d-458b-9bad-2dfa9dbd8acb) [0001789769-24-000103.rtf](/static-files/57c1e2e8-48e7-446a-a53c-a50b70a2eb00) [0001789769-24-000103.xls](/static-files/e61cfd44-2bef-4b46-a042-02db8b246e51) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001789769-24-000103) [View HTML](/node/8021/html)  \nNovember 13, 2024 | [S-3](/sec-filings/sec-filing/s-3/0001193125-24-257343) | Simplified registration form |  Registration Statements |  [0001193125-24-257343.pdf](/static-files/50f86542-6fdc-4a44-9506-5f1a19f12704) [0001193125-24-257343.rtf](/static-files/2a7b6b40-d6d0-4811-a1a1-af48580e1d34) [0001193125-24-257343.xls](/static-files/e534f139-4595-4ecd-aaf2-5cf15aad3ed7) [View HTML](/node/8026/html)  \nOctober 25, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000895345-24-000481) | An amendment to the SC 13G filing |  Other |  [0000895345-24-000481.pdf](/static-files/93fa543b-7201-4754-8ca0-b0554a5c145c) [0000895345-24-000481.rtf](/static-files/672d3eaa-d605-423c-8b12-82fc74b8865a) [0000895345-24-000481.xls](/static-files/09bc5f7b-cbdf-452e-9a5d-25b9f43145b7) [View HTML](/node/7996/html)  \nOctober 22, 2024 | [SC 13D/A](/sec-filings/sec-filing/sc-13da/0001193125-24-241198) | An amendment to a SC 13D filing |  Other |  [0001193125-24-241198.pdf](/static-files/1235aed3-0645-49cc-a8a8-7cc61fb176a6) [0001193125-24-241198.rtf](/static-files/b60834b1-e338-47cc-9574-e45f52fb730c) [0001193125-24-241198.xls](/static-files/2bcee7df-83d5-467a-8aff-a3004d19c58a) [View HTML](/node/7991/html)  \nSeptember 27, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0001193125-24-227976) | A statement of beneficial ownership of common stock by certain persons |  Other |  [0001193125-24-227976.pdf](/static-files/3d7ec9e5-0285-4890-a534-dcef5730c19d) [0001193125-24-227976.rtf](/static-files/b7f50388-19f3-480a-aa21-a72c601b1af2) [0001193125-24-227976.xls](/static-files/90290f47-8070-4dc0-aded-5b07657ea4fe) [View HTML](/node/7981/html)  \nSeptember 27, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0000895345-24-000383) | A statement of beneficial ownership of common stock by certain persons |  Other |  [0000895345-24-000383.pdf](/static-files/2fbb8965-136a-4c8f-a2f0-17347dd9f3de) [0000895345-24-000383.rtf](/static-files/8dba425d-2f38-4257-904b-fcb0894e3730) [0000895345-24-000383.xls](/static-files/c3db2cfb-279b-4dc0-8b39-cf2a4e68bb16) [View HTML](/node/7986/html)  \n  \nDisplaying 1 - 10 of 191 results\n\nData provided by [Kaleidoscope](https://www.kscope.io).\n\n[](# \"Back to top\")\n\n√ó\n"
        }
      ]
    },
    {
      "section_name": "IR Resources",
      "links": [
        {
          "title": "FAQs",
          "url": "https://ir.instilbio.com/ir-resources/investor-faqs",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# FAQs\n\n[Show All](#)\n\nWhere are Instil Bio's corporate headquarters located?\n\n‚Ä¢ Instil Bio‚Äôs corporate headquarters and executive offices are in Dallas, TX.\n\nWhere is the company incorporated?\n\n‚Ä¢ Instil Bio is incorporated in Delaware.\n\nDoes Instil Bio pay dividends?\n\n‚Ä¢ Instil Bio does not pay a dividend and does not expect to pay one in the foreseeable future.\n\nWhat does Instil Bio‚Äôs fiscal year end?\n\n‚Ä¢ Instil Bio‚Äôs fiscal year ends on December 31 of each year.\n\nWhat exchange does Instil Bio trade on? \n\n‚Ä¢ Instil Bio‚Äôs shares are traded on Nasdaq.\n\nWhat is Instil Bio‚Äôs ticker symbol?\n\n‚Ä¢ Instil Bio‚Äôs ticker symbol is ‚ÄúTIL‚Äù.\n\nWho makes up the Instil Bio‚Äôs Executive Management team and Board of Directors? \n\n‚Ä¢ Members of the Instil Bio‚Äôs Executive Team and Board of Directors may be found [here](https://instilbio.com/about/).\n\nHow do I contact Instil Bio Investor Relations?\n\n‚Ä¢ You can reach Instil Bio Investor Relations by email at investor.relations@instilbio.com\n\nHow can I get added to Instil Bio‚Äôs mailing list?\n\n‚Ä¢ You can sign up for e-mail alerts notifying you of new press releases, SEC filings or corporate actions and events by clicking [here](https://instilbio.gcs-web.com/ir-resources/email-alerts).\n\n[](# \"Back to top\")\n\n√ó\n"
        }
      ]
    }
  ]
}